Infosys Public Services, a US-based subsidiary of Infosys, has been selected by Prime Therapeutics, a leading pharmacy benefit manager (PBM), will set up a testing centre of excellence (COE) and consolidate the delivery of its application testing services as part of a new three-year contract.
Prime Therapeutics will streamline and optimise its quality assurance (QA) and testing services as well as enhance its competitiveness with Infosys Public Services’ expertise and world-class delivery model. Prime Therapeutics also expects to expand the capabilities of its QA organisation and gain efficiencies in managing a large scale QA department.
“We look forward to bringing our deep experience in the healthcare industry and pharmacy benefit management in particular as well as globally benchmarked QA and testing service delivery to Prime Therapeutics,” said Eric Paternoster, President and Chief Executive Officer, Infosys Public Services.
As part of the contract, Infosys Public Services will consolidate and standardise Prime Therapeutics’ QA and testing services, currently provided by multiple service providers. Infosys Public Services will support Prime Therapeutics’ QA organisation as they deliver across all lines of the business and increase the agility of the QA department. Prime Therapeutics will be able to improve application and service quality, and reduce IT costs with Infosys Public Services’ range of QA and testing frameworks, techniques, tools and accelerators.
“The rapidly evolving healthcare industry demands faster response and improved information technology quality to ensure Prime Therapeutics’ competitiveness,” said Jim Graham, Vice President Application Development, Prime Therapeutics. “Transforming our testing and QA services will help us achieve that and better meet the needs of health plans, employers, and government programmes.”
EP News Bureau – Mumbai
- Advertisement -
